New Report Showcases Pharmaceutical Industry's Medical Booth Practices at Annual Conferences

Wednesday, May 23, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

CHAPEL HILL, N.C., May 22, 2018 /PRNewswire/ -- An engaging exhibit booth at annual medical conferences is one of the key

ways to raise awareness and educate healthcare professionals about a pharmaceutical company's pipeline and products.

However, new technologies and a conservative compliance mindset have made it challenging for some medical communications leaders

in pharma to showcase their company's pipeline and products to thought leaders attending medical congresses or conferences. To share current medical booth practices, research and consulting leader Best Practices, LLC has published a new study, "Medical Meeting Excellence: Best Practices in Improving Medical Information/Affairs Booth Impact at Critical Medical Congresses."

The study, which includes a Hematology/Oncology segment, found that the HemOnc therapeutic area is more aggressive than other therapeutic areas insofar as the methods they use to display medical information in exhibit booths. At least 50 percent of the HemOnc segment use more than one type of display method for 13 of the 17 medical content types evaluated in the study. A majority of the HemOnc segment use static panels, handouts, interactive and iPads to display their pipeline, clinical trial, and disease state information, according to the study.

The 86-page report presents insights on questions such as:

  • What types of content do companies display at medical congresses/conferences and do they share it proactively or reactively?
  • How do they display the content – static panels, interactively, iPads or other methods?
  • How prevalent is it for companies to host poster/investigator receptions and what type of content is used?

Pharmaceutical leaders can use the research results to compare their congress booth content and display approaches with industry peers.

Best Practices, LLC engaged 21 Medical Affairs leaders at 20 pharmaceutical companies for this research project. In addition to utilizing a survey to collect quantitative data, the study included four executive interviews to collect qualitative data. Data in this research are presented into two segments: Hematology/Oncology vs. Non-Hematology/Oncology and Size (Large vs. Small Companies).

To access the full report or to download a complimentary summary containing insights found in this report, click on the following link:  

For related research, visit the Best Practices, LLC Web site at 

ABOUT BEST PRACTICES, LLC Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis.


Cision View original content:

SOURCE Best Practices, LLC

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store